BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 27346583)

  • 1. Oxidized phospholipids and lipoprotein-associated phospholipase A
    Tselepis AD
    J Biomed Res; 2018 Jan; 31(1):13-22. PubMed ID: 27346583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autotaxin interacts with lipoprotein(a) and oxidized phospholipids in predicting the risk of calcific aortic valve stenosis in patients with coronary artery disease.
    Nsaibia MJ; Mahmut A; Boulanger MC; Arsenault BJ; Bouchareb R; Simard S; Witztum JL; Clavel MA; Pibarot P; Bossé Y; Tsimikas S; Mathieu P
    J Intern Med; 2016 Nov; 280(5):509-517. PubMed ID: 27237700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Mild to Moderate Aortic Valve Stenosis Progression With Higher Lipoprotein(a) and Oxidized Phospholipid Levels: Secondary Analysis of a Randomized Clinical Trial.
    Capoulade R; Yeang C; Chan KL; Pibarot P; Tsimikas S
    JAMA Cardiol; 2018 Dec; 3(12):1212-1217. PubMed ID: 30476957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma.
    Tellis CC; Tselepis AD
    Biochim Biophys Acta; 2009 May; 1791(5):327-38. PubMed ID: 19272461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
    Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidized phospholipid modification of lipoprotein(a): Epidemiology, biochemistry and pathophysiology.
    Koschinsky ML; Boffa MB
    Atherosclerosis; 2022 May; 349():92-100. PubMed ID: 35606081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease.
    Tsimikas S; Tsironis LD; Tselepis AD
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2094-9. PubMed ID: 17626905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiological role and clinical significance of lipoprotein-associated phospholipase A₂ (Lp-PLA₂) bound to LDL and HDL.
    Tellis CC; Tselepis AD
    Curr Pharm Des; 2014; 20(40):6256-69. PubMed ID: 24953389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heritability of Biomarkers of Oxidized Lipoproteins: Twin Pair Study.
    Rao F; Schork AJ; Maihofer AX; Nievergelt CM; Marcovina SM; Miller ER; Witztum JL; O'Connor DT; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1704-11. PubMed ID: 25953646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of Autotaxin With Lipoprotein(a) in Patients With Calcific Aortic Valve Stenosis.
    Bourgeois R; Devillers R; Perrot N; Després AA; Boulanger MC; Mitchell PL; Guertin J; Couture P; Boffa MB; Scipione CA; Pibarot P; Koschinsky ML; Mathieu P; Arsenault BJ
    JACC Basic Transl Sci; 2020 Sep; 5(9):888-897. PubMed ID: 33015412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein(a), Oxidized Phospholipids, and Aortic Valve Microcalcification Assessed by 18F-Sodium Fluoride Positron Emission Tomography and Computed Tomography.
    Després AA; Perrot N; Poulin A; Tastet L; Shen M; Chen HY; Bourgeois R; Trottier M; Tessier M; Guimond J; Nadeau M; Engert JC; Thériault S; Bossé Y; Witztum JL; Couture P; Mathieu P; Dweck MR; Tsimikas S; Thanassoulis G; Pibarot P; Clavel MA; Arsenault BJ
    CJC Open; 2019 May; 1(3):131-140. PubMed ID: 32159096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis.
    Capoulade R; Chan KL; Yeang C; Mathieu P; Bossé Y; Dumesnil JG; Tam JW; Teo KK; Mahmut A; Yang X; Witztum JL; Arsenault BJ; Després JP; Pibarot P; Tsimikas S
    J Am Coll Cardiol; 2015 Sep; 66(11):1236-1246. PubMed ID: 26361154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein(a), Oxidized Phospholipids, and Coronary Artery Disease Severity and Outcomes.
    Gilliland TC; Liu Y; Mohebi R; Miksenas H; Haidermota S; Wong M; Hu X; Cristino JR; Browne A; Plutzky J; Tsimikas S; Januzzi JL; Natarajan P
    J Am Coll Cardiol; 2023 May; 81(18):1780-1792. PubMed ID: 37137588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein-associated phospholipase A2 activity, genetics and calcific aortic valve stenosis in humans.
    Perrot N; Thériault S; Rigade S; Chen HY; Dina C; Martinsson A; Boekholdt SM; Capoulade R; Le Tourneau T; Messika-Zeitoun D; Engert JC; Wareham NJ; Clavel MA; Pibarot P; Smith JG; Schott JJ; Mathieu P; Bossé Y; Thanassoulis G; Arsenault BJ
    Heart; 2020 Sep; 106(18):1407-1412. PubMed ID: 32636298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a) Associated Molecules are Prominent Components in Plasma and Valve Leaflets in Calcific Aortic Valve Stenosis.
    Torzewski M; Ravandi A; Yeang C; Edel A; Bhindi R; Kath S; Twardowski L; Schmid J; Yang X; Franke UFW; Witztum JL; Tsimikas S
    JACC Basic Transl Sci; 2017 Jun; 2(3):229-240. PubMed ID: 29147686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
    Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
    Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidized Phospholipids and Risk of Calcific Aortic Valve Disease: The Copenhagen General Population Study.
    Kamstrup PR; Hung MY; Witztum JL; Tsimikas S; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1570-1578. PubMed ID: 28572160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense inhibition of apolipoprotein (a) to lower plasma lipoprotein (a) levels in humans.
    Graham MJ; Viney N; Crooke RM; Tsimikas S
    J Lipid Res; 2016 Mar; 57(3):340-51. PubMed ID: 26538546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute impact of apheresis on oxidized phospholipids in patients with familial hypercholesterolemia.
    Arai K; Orsoni A; Mallat Z; Tedgui A; Witztum JL; Bruckert E; Tselepis AD; Chapman MJ; Tsimikas S
    J Lipid Res; 2012 Aug; 53(8):1670-8. PubMed ID: 22628616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current landscape of lipoprotein(a) in calcific aortic valvular disease.
    Hsieh G; Rizk T; Berman AN; Biery DW; Blankstein R
    Curr Opin Cardiol; 2021 Sep; 36(5):542-548. PubMed ID: 34397461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.